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Abstract: Dietary supplementation with perilla seed oil, a vegetable oil rich in a -lin·
olenic acid, inhibits the generation of leukotrienes(LTs) by leucocytes in patients with
bronchial asthma. We examined the factors that affect the suppression of LT genera-
tion by leucocytes with perilla seed oil-rich supplementation in patients with asthma,
by comparing the clinical features of patients with asthma, whose generation of
leukotriene (LT) C4 was suppressed by dietary supplementation with perilla seed oil
(n-3 fatty acids) (group A), with those of patients who showed no suppression of
LTC4 generation (group B). Group A showed a significant increase in the generation of
LTB4 and L TC4 by leucocytes after corn oi I-rich supplementation (n-6 fatty acids), and
a significant decrease in the generation of LTB4 and LTC4 after perilla seed oil-rich
supplementation (n-3 fatty acid). However, this was not observed in group B. The level
of serum IgE and peak expiratory flow (PEF) in group A were significantly higher
than in group B. Furthermore, the serum levels of LDL-cholesterol, ~-lipoprotein and
phospholipid were significantly lower in group A than in group B. These results suggest
that the clinical features differ between these two asthmatic populations with respect
to suppression of LTB4 and LTC4 generation by n-3 fatty acids in perilla seed oil-rich
supplementat ion.
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Introduction
Bronchial asthma is characterized by aIr-
way inflammation followed by bronchial
hyperresponsiveness to non-specific stimuli.
Airway inflammation is a main feature in
the pathophysiology of asthma, in which
various cytokines are released from inflam-
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matory cells. Leukotrienes (LTs) are one of
the most important chemical mediators re-
leased from inflammatory cells. Peptide LTs
(LTC4, D4 and E4) have a bronchoconstrict-
ing action and participate in the onset of
asthma attacks 1. 2).
Our previous studies demonstrated that
both histamines and LTC4 participate in the
onset mechanism of atopic asthma, whereas
only LTC4 participates in the onset of non-
atopic asthma3). Furthermore, LTB4 plays an
important role in the asthmatic response by
recruiting leucocytes to allergic reaction sites
in the airway. These LTs are generated from
arachidonic acid (AA) , which is released
from membrane phospholipids during cell ac-
tivation through the 5-lipoxygenase path-
way'). LTB4 and LTC4 are generated from
linoleic acid (LA) (n-6 fatty acid) through
AA, and LTB5 and LTC5 are generated from
a -linolenic acid (a -LNA) (n-3 fatty acid)
through eicosapentaenoic acid (EPA) in the
same 5-lipoxygenase pathway.
Polyunsaturated fatty acids (PUFAS) of
the n-3 series - EPA and docosahexaenoic acid
(DHA) - suppress the production of LTs by
antagonistic metabolism, which occur at
the level of LT hydrolase through the 5-
lipoxygenase pathway. At this level, they
may exert an effect by altering LT genera-
tion by leucocytes. PUFAs reportedly demon-
strated anti-inflammatory effeCts in patients
with chronic inflammatory diseases such as
rheumatoid arthritis, psoriasis, and chronic
inflammatory bowel disease 5 -ll) •
Several studies have suggested the benefi-
cial effects of EPA or fish oil on bronchial
asthma12- 15J • whereas others have demon-
strated no such beneficial effectsl~ 17).
Our previous studies showed that the die-
tary supplementation with perilla seed oil, a
vegetable oil rich in a -LNA inhibits the gen-
eration of LTs by leucocytesI8). In the present
study. we examined the factors that affect
the suppression of generation of LTs by
leucocytes with perilla seed oil rich supple-
mentation in patients with asthma.
Subjects and Methods
The subjects were 19 patients (12 females
and 7 males) with asthma. All patients were
admitted to our hospital for treatment of
asthma. Their mean age was 58.9 years old
(range 22 to 73 years). Their mean serum IgE
at admission was 372.3 ± 513.8U/ mt (range
16.4 to 1681U/mI).
Bronchial asthma was evaluated according
to the criteria of the International Consensus
of Diagnosis and Management of AsthmaI9).
All patients demonstrated a reversible airway
response, as indicated by a 15% or greater
increase in their forced expiratory volume in
one second (FEVLO) after inhaled bron-
chodilator use. Informed consent was ob-
tained from all patients. At the time of the
study, all patients were undergoing regular
treatment with long-acting oral theophyline,
I' 2 adrenergic agonists inhalation and glu-
cocorticosteroid (beclomethasone dipropionate
: BDP) inhalation. The mean dose of inhaled
BDP was 347.4±238.9tL g /day.
Peak expiratory flow (PEF) in the early
morning and evening was recorded in all sub-
jects using a peak-flow meter (Assess: Health
Scan Products Inc., Cedar Grove, NJ, USA).
The subjects were classified into 2 groups
according to the degree of suppression of gen-
eration of LTC4 by leucocytes after dietary
supplementation with perilla seed oil. Pa-
tients who showed suppressed generation af-
ter two weeks of supplementation were classi-
fied as "Diet Inhibition Group" (group A),
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and those who showed no suppression were
classified as "No Inhibition Group" (group B).
Group A subjects included 2 females and 5
males with a mean age of 54.3 years (range
22 to 72 years). Group B subjects included
10 females and 2 males with a mean age of
61.6 years (range 55 to 73 years).
The concentration of the serum total cho-
lesterol, triglyceride, high density lipoprotein
(HDL)-cholesterol, and phospholipid were as-
sayed using a previously reported enzymatic
method2ll-23). Low density lipoprotein (LDL)-
cholesterol concentration was calculated from
the formula [(serum total cholesterol) - (HD
L-cholesterol) - 0.2 x (triglyceride)J
(Friedwald's convert)24l. fJ -lipoprotein was
assayed by turbidimetry. Serum IgE level was
estimated by the radioimmunosorbent test
(RIST).
Pulmonary function tests, forced vital ca-
pacity (FVC) and forced expiratory volume
in one second (FEVl.o) were performed by
Chestac 33(Chest Co.Tokyo, Japan) linked to
a computer while the subjects were in an
attack-free state, and the percentage of pre-
dicted values were calculated.
The generation of LTB4 and LTC4 by pe-
ripheral leucocytes was assessed by a method
previously described 1. 3). Cells were separated
by counterflow centrifugation elutriation us-
ing a JE 6B rotor (Beckman Co., Geneva,
Switzerland)"" as described previously'·26). The
number of cells was then adjusted to 5 X 106
/ml in Tris ACM (composition: 1 ml of 0.1
mol/ICa2+, 0.5ml of O.lmol/1 Mg2+ and
98.5 ml Tris A buffer; Trizma preset crystal,
pH 7.7; Sigma Chemical Co., St. Louis, Mo,
USA). The Ca ionophore A23187 (1 f1 g) was
added to the cell suspension. The mixed solu-
tion was incubated for 15 min at 4"C. Quan-
tification of LTB4 and LTC4 by HPLC
analysis was performed by a method de-
scribed by Lam et al2'7l. The extraction of LTs
was performed using a C18 Seppak (Waters
Associates, Milford MA). The concentrations
of LTB4 and LTC4 were analyzed by HPLC,
Model 510 (Waters Associates, Milford, MA),
equipped with an ultraviolet detector. The
column used was a 5mrn x 10cm Radial-Pax car-
tridge (Shimazu Co., Kyoto, Japan). The re-
sults are expressed as ng/5 X 106 cells.
The subjects consumed 10-20 g of corn oil
(rich in LA) per day as salad dressing and
/ or mayonnaise instead of other oils for the
first 2 weeks and the same amount of perilla
seed oil (rich in a -LNA) per day for the sub-
sequent 2 weeks. Other dietary components
were not changed, and the amount of oil used
in the diet and supplemented diet was re-
corded throughout the study period.
Data are expressed as mean ± standard
deviation (SD). Statistically significant dif-
ferences between the means were estimated
using the Student's t-test. A p value of <
0.05 was regarded as significant.
Results
LTB4 generation by leucocytes was influ-
encedby dietary supplementation with corn
oil and perilla seed oil as evidenced by a sig-
nificant Increase following corn oil-rich
supplementation for two weeks (P<0.05),
and a significant decrease following perilla
seed oil-rich supple-mentation for two weeks
(P<0.05) in group A (Fig. n. Similarly,
LTC4 generation by leucocytes increased sig-
nificantly following corn oil-rich supplemen-
tation in group A. However, LTC4 generation
did not change following corn oil-rich sup-
plementation in group B. A significant differ-
ence in LTC4 generation was observed be-
tween group A and group B after corn oil-
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Fig. 1. Changes in LTB4 generation in the
two study groups. LTB4 generation
increased significantly following corn
oil rich supplementation CP<O.05) and
decreased significantly following per-
illa seed oil supplementation for two
weeks in group A CDiet Inhibition
Group) C.-.) (P<O.05). In con-
trast, LTB4 generation did not change
significantly following either corn oil
or perilla seed oil rich supple-
mentation for two weeks In group B
(No Inhibition Group) C•...• ).
* :P<O.05
Fig. 2. Changes in LTC4 generation in the
two study groups. LTC4 generation
increased significantly following corn
oil rich supplementation for two
weeks in group A C.-.). In con-
trast, LTC4 generation did not change
significantly following corn oil rich
supplementation in group B C.···.).
LTC4 generation differed significantly
between the groups following corn oil
rich supplementation for two weeks.
*P<O.01 a; P<O.05.
Table. 1. Comparison of morning and evening
PEF value between the two groups.
rich supplementation for 2 weeks (P<O.05)
(Fig. 2).
Morning and evening PEF values prior to
inhalation of the f3 2 agonist were signifi-
cantly higher in Group A than in group B
during the study period (Table 1). The PEF
value tended to increase in both group A and
group B following dietary supplementation,
although these increases were not significant.
The % FVC value did not differ between
the two study groups before dietary supple-
mentation; However, this value tended to in-
crease in both groups following dietary sup-
plementation. In group A, %FVC showed a
significant increase following perilla seed oil
PEf value (Umin)
Before com oil Betore perilla seed oil After perilla seed oil
Group A Morning 315.5± 121.7' 357.1:t 138.3' 351.4±131.I'
Evening 3S7.1±12S.7· 377.1±12S.1d 394.3±120.S'
Group B Morning 173.3±121.7' 200.8±60.$' 222.1 ±SO.9'
Evening 204.2±59.5· 231.7±47.6d 232.S±SO.S'
Group A: Suppression of LTC4 generation by dietary supplementation
with periUa seed oil. Group 8 : no suppression of LTC4 generation observed
PEF was significantly higher in group A than group Bduring the studY period.
a.b,c,d.e and f:P<O.05 .
rich supplementation for 2 weeks (Table 2).
FEVl.O showed no significant change during
the study period, although the value tended
to increase in group A.
The mean level of serum IgE was 794U/ml
Crange from 117U/ml to 1681U/ml) in
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Table. 2. Comparison of %FVC value
between the two study groups.
Table. 3. Serum lipometabolism III the two
study groups
96FVC (96)
Before com oil Before perilla seed oil After perilla seed 011
Group A GroupB Pvalue
Discussion
Group A: Suppression of LTC4 generation by dietary supplementation
with perilla seed oil. Group B: no suppression of LTC4 generation observed
Asignificant increase after two weeks of perilla seed oil supplementation
in group Awas seen. lIE:P<O.OS
LTs represent a major chemical mediator in
asthma and play an important role in late
asthmatic reaction (LAR). Large quantities
Group A: Suppression of LTC4 generation by dietary
supplementation with perilla seed oil.
Group B: no suppression of LTC4 generation observed
NS: not significant
Total cholesteroICnv/cIl) I87.9±34.9 l08.4±l3.S NS
TrlglycerideCnv/cIl} 6S.I±30.7 79.9±3S.3 NS
HDL-CholesteroIClIll/cll} 63.6±17.3 7Z.I±l6.S NS
LDL-CholesteroICnv/cIl} 9S.7±31.0 I 36.4±43.1 P<O.OS
IJ -llpoprotelnCnv/cIl} 307±S8.l 434±l4.0 P<O.OS
Phosphlipid(nv/cIl} 189.all.7 224.6±30.3 P<O.OS
of these mediators are synthesized and/or
released by inflammatory cells during an al-
lergic reaction. The generation of LTB4 is
reduced by n-3 fatty acids28. 29). LTB4 genera-
tion from LA and LTB5 from a -LNA have
similar biological activities. However, the
action of LTB5 is much weaker than that
of LTB4. Cysteinyl LTs (LTC4, LTD4 and
LTE4) have been implicated in the pathogene-
sis of allergen-induced airway responsiveness
as potent contractile agonists for airway
smooth,' muscle by mediating a later part
of immediate airway obstruction - fall in
FEVl.o - after allergen exposure:Jl. 30.
Dietary supplementation with perilla seed
oil, which is rich in a -LNA has been proposed
as a means to suppress the LT4 series genera-
tion by leucocytes and increase the generation
of LT5 series through the 5-lipoxygenase
pathway. Our previous study supported .this
hypothesis by demonstrating a significant
suppression of LTB4 and LTC4 generation by
leucocytes following perilla seed oil-rich sup-
plementation!S).
Conversely, supplementation with corn oil,
which is rich in LA, has been proposed to
increase the generation of LTB4 and LTC4
from AA through the 5-lipoxygenase path-
way.
96.8±8.6
104.3±32.2-
*
104±27.9
96.3±16.3
•
••
•
•
".
#I I::·
c;roupA Group B
93.8±2B.9-
93.8±lS.8Group B
Group A
group A, and 126U/ml (range from 16.4IU
/ml to 353U/ml) in group B. The mean
level was significantly higher in group A
than in group B (P<O.02) (Fig.3). As a
marker of serum lipometabolism, the levels
of LDL-cholesterol, /3 -lipoprotein and phos-
phlipid were all significantly lower in group
A than in group B prior to dietary sup-
plementation (Table 3).
lOO
Fig. 3. Serum IgE levels in the two study
groups. Mean IgE level was signifi-
cantly higher in group A than group
B. *: P<O.02
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The effects of n-3 fatty acids such as EPA
and fish oil on asthma are controversial.
Some investigators have suggested beneficial
effects of n-3 fatty acids on asthma12•'5),
whereas others have reported little effect'6.l7).
In the present study, the clinical features of
patients whose generation of LTC4 by leu-
cocytes was suppressed by perilla seed oil-rich
supplementation (group A) were examined in
comparison with those of patients who dem-
onstrated no suppression (group B). LTB4
and LTC4 generation by leucocytes in group
A significantly increased following corn oil-
rich supplementation, whereas a significant
decrease was observed following perilla seed
oil-rich supplementation. In contrast, LTB4
and LTC4 generation in group B did not
change following supplementation with either.
dietary substance. These results indicate that
two asthmatic populations exist with respect
to suppression of LTB4 and LTC4 generation
by n-3 fatty acids in perilla seed oil, such
that patients who demonstrate suppression of
LT generation by leucocytes are sensitive to
PDFAs in their diet. The results also suggest
that n-3 fatty acid administration are effec-
tive in these patients.
The subjects in group A showed signifi-
cantly higher PEF compared to group B, sug-
gesting that group A subjects had a clinically
better state of asthma than group B. The
significant improvement of %FVC in group
A following perilla seed oil-rich supple-
mentation indicates that cysteinyl LTs could
affect respiratory function.
LTs, which are IgE-dependent chemotactic
factors, mediate IgE-dependent constriction of
human bronchi32. 38). A significant influence of
dietary PDFA on the concentration of plasma
IgE has been demonstrated by several re-
searchers'" 38). Gosset P et al. demonstrated
that IgE-dependent stimulation of alveolar
macrophages (AMs) produces a neutrophil
and eosinophil chemotactic activity that can
be observed in a low molecular weight frac-
tion, possibly related to LTs. Furthermore,
they emphasized the role of AMs in inflam-
matory lung processes during allergic asth-
ma34). Watanabe S et al. reported a signifi-
cantly lower IgE antibody response against
egg albumin in mice on a high a -LNA diet
compared to those on a high LA diet, and
emphasized the suppressive effects of a high
a -LNA diet on the severity of immediate-
type allergic hypersensitivity, together with
the suppressive effects on the formation of
lipid-derived allergic mediators, including
LTs38). In the present study, group A subjects
'. had higher IgE levels than group B subjects,
indicating that IgE-dependent allergic reaction
is influenced by LTB4, LTC4, and a -LNA di-
ets through LT generation by leucocytes.
Previous reports have suggested that PDFA
- particularly a -LNA - diets decrease serum
cholesterol, LDL-cholesterol39.43). Recent die-
tary trends have included high consumption
of saturated fatty acids and n-6 PDFAs and
low n-3 PDFAs in our country"). The present
results showed significantly lower levels of
serum LDL-cholesterol, f3 -lipoprotein and
phos-pholipid in group A compared to group
B prior to the dietary supplementation, sug-
gesting that group A subjects consumed n-3
fatty acids rich diets prior to the beginning
of this study. The present results indicate
that dietary supplementation with a -LNA
affects LT generation by leucocytes through
varIOUS factors such as IgE and lip-
ometabolism. In particular, perilla seed oil
supplementation rich in a ~LNA may be effec-
tive in the treatment of asthma in select sub-
jects.
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a-リノレン酸甲豊富なェゴマ油の食事は気管
支鳴息患者の白血球ロイコトリエン (LT)産生
能を抑制する｡気管支噂息患者の内,エゴマ油食
によりLTC4の産生が抑制された群 (A群)と
抑制されない群 (B群)の臨床データを比較す
52
ることにより,気管支鳴息患者の白血球ロイコト
リエン産生能に影響する因子を検討した｡A群は
コーン油 (n-6系脂肪酸)の豊富な食事後,白血
球LTB4,LTC4の産生能が増加し,エゴマ
油 (n-3系脂肪酸)の豊富な食事後LTB4,
LTC4の産生能が減少した｡これらの変化はB
群では認められなかった｡A群のIgE値,ピー
クフロー (PEF)値はB群に比し,有意に高値
であった｡またLDL-コレステロール,β-リ
ポ蛋白,リン脂質はA群ではB群に比 し,有意に
低値であった｡これらの結果はエゴマ油の豊富な
食事のn-3系脂肪酸によるLTB4,LTC4の
産生能の抑制に関して2群の気管支噂息患者群問
に臨床データの相違があることを示唆している｡
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